Käsitteen tiedot
Käytettävä termi
Neuroleptic Malignant Syndrome
Tyyppi
-
Topical Descriptor
Ohjaustermit
- NMS (Neuroleptic Malignant Syndrome)
- NMSs (Neuroleptic Malignant Syndrome)
Huomautus
- caused by tranquilizing agents so do not use /chem ind
Käyttöhuomautus
- A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
Huomautus muutoshistoriasta
- 1986(1985)
Muunkieliset termit
-
ruotsi
-
suomi
-
maligni neuroleptioireyhtymä
-
maligni neuroleptisyndrooma
-
malignt neuroleptikasyndrom
-
neuroleptisyndrooma
-
pahanlaatuinen neuroleptioireyhtymä
-
pahanlaatuinen neuroleptisyndrooma
-
syndroma neurolepticum malignum
URI
http://www.yso.fi/onto/mesh/D009459
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}